Company Filing History:
Years Active: 2018
Title: The Innovative Contributions of Nam Ye Kim
Introduction
Nam Ye Kim is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of novel therapeutic antibodies. With a total of 3 patents to his name, Kim's work is paving the way for advancements in targeted cancer therapies.
Latest Patents
Kim's latest patents include groundbreaking inventions such as a dual-target antibody that specifically targets VEGFR-2 and DLL4. This invention encompasses a novel form of the antibody, a gene encoding it, a recombinant expression vector, and host cells transformed with this vector. Additionally, he has developed a pharmaceutical composition that includes this dual-target antibody, which has the potential to enhance treatment efficacy. Another significant patent involves a fully human antibody that specifically binds to c-Met. This c-Met-specific antibody, isolated from a human Fv(ScFv) phage library, demonstrates high affinity and specificity, offering promising therapeutic applications.
Career Highlights
Nam Ye Kim is currently associated with Pharmabcine Inc., where he continues to innovate and contribute to the field of biotechnology. His work is characterized by a strong focus on developing effective therapeutic solutions for cancer treatment.
Collaborations
Kim collaborates with notable colleagues, including Jin San Yoo and Weon Sup Lee, who share his commitment to advancing medical science through innovative research.
Conclusion
Nam Ye Kim's contributions to biotechnology, particularly in the development of targeted antibodies, highlight his role as a leading inventor in the field. His patents reflect a dedication to improving therapeutic options for patients, showcasing the impact of his work on future medical advancements.